Model Benefit Language
Model Benefit Language for Coverage with Evidence Development
Extending CMS’s “Coverage with Evidence Development” (CED) beyond the Medicare population has great appeal as a creative approach to encourage decision-maker-oriented research into important—but inadequately proven—emerging technologies. Several obstacles currently stand in the way of this approach, however. Under a grant from the California HealthCare Foundation, the Center for Medical Technology Policy has partnered with a group of health plans, patients, physicians, employers and policy leaders to develop a conceptual framework that addresses these obstacles
MBL Working Group Members
The Model Benefit Language working group represents the full spectrum of Coverage with Evidence Development stakeholders, including health insurers, device manufacturers, health consumer advocates, research institutions, and others.
